Protagonist Therapeutics Inc buy melinda
Start price
06.03.18
/
50%
€18.54
Target price
09.03.18
€20.57
Performance (%)
13.14%
End price
09.03.18
€20.97
Summary
This prediction ended on 09.03.18 with a price of €20.97. The BUY prediction by melinda finished with a performance of 13.14%. melinda has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protagonist Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
| iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
| iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
| iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
Comments by melinda for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 07/03 Ergebnisse Veröffentlichung
6. März 2018, 16:30 UND FDA genannt Orphan - Medikament für die TKR-300 Protagonistin Therapeutics zur Behandlung von Beta-Thalassämie
Protagonistin Therapeutics, Inc. (NASDAQ: PTGX) hat heute bekannt gegeben , dass die Food and Drug Administration (FDA) die Orphan Drug Designation erteilt hat ...
Current prediction by melinda for Protagonist Therapeutics Inc
Stopped prediction by melinda for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€6.25
13.12.19
13.12.19
€20.00
04.11.21
04.11.21
392.80%
05.11.21
05.11.21
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€10.39
17.03.19
17.03.19
€15.33
22.07.19
22.07.19
13.54%
22.07.19
22.07.19
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€13.70
14.09.17
14.09.17
€15.24
20.09.17
20.09.17
14.11%
20.09.17
20.09.17
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€15.19
14.09.17
14.09.17
€16.90
20.09.17
20.09.17
14.11%
20.09.17
20.09.17